Martin G. Sanda MD

Martin G. Sanda, MD, is Professor and Chair of Urology at Emory University School of Medicine and Director of the Prostate Cancer Center at Emory’s Winship Cancer Institute. Dr. Sanda is a surgeon-scientist with expertise in prostate cancer clinical care, as well as in translational and outcomes research. He has held continuous NIH funding since 1996 as the PI of studies evaluating prostate cancer biomarkers, tumor immunology, and quality of life that have led to more than 150 publications which have been cited over 10,000 times in the biomedical literature. Dr. Sanda’s clinical practice is focused on developing new surgical and non-surgical approaches to cancer care and to improving the quality of life among cancer survivors, with surgical expertise in robotic prostatectomy.

After receiving his BA in molecular biophysics and biochemistry from Yale University in 1983, Dr. Sanda completed his MD degree at Columbia University, trained as a general surgery resident at the Medical College of Virginia and surgical oncology fellow at the National Cancer Institute before completing his urology residency at Johns Hopkins Hospital. Dr. Sanda served on the faculty at the University of Michigan from 1995-2003, where he attained tenure as Associate Professor before moving to Harvard in 2003, where he rose to the position of Professor of Urology at Harvard Medical School and Beth Israel Deaconess Medical Center, before assuming his current position at Emory in 2013.